NCT00331136View on ClinicalTrials.gov

Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Uncomplicated Plasmodium Falciparum Malaria
Interventions
DRUG

Pyronaridine-Artesunate

Once a day for 3 days

Trial Locations (1)

Unknown

Medical Research Unit, Albert Schweitzer Hospital, Lambaréné

All Listed Sponsors
collaborator

Shin Poong Pharmaceuticals

INDUSTRY

collaborator

Institute of Tropical Medicine, University of Tuebingen

OTHER

lead

Medicines for Malaria Venture

OTHER

NCT00331136 - Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria | Biotech Hunter | Biotech Hunter